OSE Immunotherapeutics SA
OSE Immunotherapeutics SA focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. Its products include Tedopi that is in Phase III clinical stage for the treatment of no…
Biotechnology
FR, Nantes [HQ]
Balance Sheet
12 Sheets · Starting from 2012In Million EUR. Margins, Growth Rates In %
| Metric | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | - - | - - | 1.00 | 16.00 | 89.00 | 77.00 | 76.00 | 88.00 | 96.00 | 101.00 | 91.00 | 81.00 | |
|
Current
|
- - | - - | 1.00 | 16.00 | 36.00 | 23.00 | 23.00 | 33.00 | 39.00 | 44.00 | 37.00 | 30.00 | |
| Cash And Equivalents | - - | - - | 1.00 | 9.00 | 14.00 | 9.00 | 9.00 | 25.00 | 29.00 | 33.00 | 25.00 | 18.00 | |
| Assets | - - | - - | 1.00 | 16.00 | 89.00 | 77.00 | 76.00 | 88.00 | 96.00 | 101.00 | 91.00 | 81.00 | |
| Accounts Receivables (AR) | - - | - - | - - | - - | - - | -12.00 | 2.00 | 1.00 | - - | - - | - - | - - | |
| Inventory | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Short Term Investments | - - | - - | - - | 5.00 | 2.00 | 2.00 | 2.00 | - - | - - | - - | - - | - - | |
| Other Current Assets | - - | - - | - - | 1.00 | 6.00 | 11.00 | 8.00 | 1.00 | 2.00 | 2.00 | 3.00 | 2.00 | |
|
Non Current
|
- - | - - | - - | - - | - - | - - | - - | 55.00 | 57.00 | 57.00 | 54.00 | 51.00 | |
| Property, Plant, Equipment (Net) | - - | - - | - - | - - | - - | - - | - - | 2.00 | 3.00 | 5.00 | 4.00 | 4.00 | |
|
Intangible Assets
|
- - | - - | - - | - - | 52.00 | 52.00 | 52.00 | 52.00 | 52.00 | 51.00 | 48.00 | 46.00 | |
| Goodwill | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Long Term Investments | - - | - - | - - | - - | - - | -52.00 | - - | - - | - - | - - | - - | - - | |
| Other Non Current Assets | - - | - - | - - | - - | -52.00 | - - | -52.00 | - - | - - | - - | - - | - - | |
| Liabilities | - - | 1.00 | 2.00 | 2.00 | 25.00 | 21.00 | 15.00 | 30.00 | 35.00 | 53.00 | 59.00 | 59.00 | |
|
Current
|
- - | - - | 1.00 | 2.00 | 18.00 | 14.00 | 9.00 | 14.00 | 14.00 | 16.00 | 16.00 | 18.00 | |
| Accounts Payable | - - | - - | - - | - - | - - | -4.00 | -2.00 | - - | -3.00 | - - | -1.00 | - - | |
| Short Term Debt | - - | - - | - - | - - | - - | - - | - - | - - | - - | 2.00 | 3.00 | 7.00 | |
| Deferred Revenue | - - | - - | - - | - - | 10.00 | 4.00 | - - | 4.00 | 1.00 | 1.00 | - - | - - | |
| Tax Payable | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Current Liabilities | - - | - - | - - | - - | 3.00 | 1.00 | 1.00 | 4.00 | 5.00 | 10.00 | 6.00 | 4.00 | |
|
Non Current
|
- - | 1.00 | - - | - - | 1.00 | 4.00 | 3.00 | 16.00 | 21.00 | 37.00 | 42.00 | 40.00 | |
| Long Term Debt | - - | 1.00 | - - | - - | 1.00 | 4.00 | 3.00 | 9.00 | 16.00 | 30.00 | 37.00 | 35.00 | |
| Leasing Obligations | - - | - - | - - | - - | - - | - - | - - | 1.00 | 2.00 | 3.00 | 3.00 | 3.00 | |
| Deferred Non Current Tax Liabilities | - - | - - | - - | - - | 5.00 | 2.00 | 2.00 | 5.00 | 2.00 | 1.00 | 1.00 | 1.00 | |
| Other Non Current Liabilities | - - | -1.00 | - - | - - | -1.00 | -4.00 | -3.00 | - - | - - | - - | - - | - - | |
| Equity | - - | - - | - - | 14.00 | 64.00 | 55.00 | 61.00 | 58.00 | 61.00 | 47.00 | 32.00 | 22.00 | |
| Stockholders' Equity | - - | - - | - - | 14.00 | 64.00 | 55.00 | 61.00 | 58.00 | 61.00 | 47.00 | 32.00 | 22.00 | |
| Retained Earnings | -1.00 | - - | -2.00 | -5.00 | 20.00 | -10.00 | 5.00 | 34.00 | -7.00 | -21.00 | -35.00 | -57.00 | |
| Common Stock | - - | - - | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 | 3.00 | 4.00 | |
| Preferred Stock | - - | - - | 1.00 | 2.00 | - - | - - | - - | - - | - - | - - | - - | 3.00 | |
| Profit | -1.00 | - - | -2.00 | -5.00 | 20.00 | -10.00 | 5.00 | -4.00 | -16.00 | -16.00 | -17.00 | -23.00 | |
| Dividends | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Stockholders' Equity | - - | - - | - - | 18.00 | 14.00 | 63.00 | 53.00 | 21.00 | 65.00 | 65.00 | 64.00 | 72.00 | |
| Loss Other Compr. Income | - - | -1.00 | -1.00 | -2.00 | 26.00 | - - | - - | - - | - - | - - | - - | - - |